While there are slightly more incidences of colorectal cancer in men (71,860 new cases projected in the U.S. in 2014) than women (65,000), both men and women generally exhibit the same symptoms of the disease, according to Jeffrey Meyerhardt, MD, MPH, clinical director of the Center for Gastrointestinal Oncology at Dana-Farber/Brigham and Women’s Cancer Center.
In a First, Immune Checkpoint Inhibitors Show Effectiveness in Metastatic Colorectal Cancer
In trial after clinical trial, metastatic colorectal cancer has been largely undeterred by immune checkpoint inhibitors. Although these drugs have shown effectiveness in Hodgkin lymphoma, lung cancer, bladder cancer, kidney cancer, and nearly a dozen other malignancies, their track record against colorectal cancer has been lackluster, particularly for patients with the most common subtype of … Read more